1. Home
  2. YJ vs CURX Comparison

YJ vs CURX Comparison

Compare YJ & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yunji Inc. American Depository Shares

YJ

Yunji Inc. American Depository Shares

HOLD

Current Price

$1.64

Market Cap

9.4M

ML Signal

HOLD

Logo Curanex Pharmaceuticals Inc

CURX

Curanex Pharmaceuticals Inc

N/A

Current Price

$4.96

Market Cap

7.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YJ
CURX
Founded
2015
2018
Country
China
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4M
7.9M
IPO Year
2019
2024

Fundamental Metrics

Financial Performance
Metric
YJ
CURX
Price
$1.64
$4.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 77.8K
23.9K
Earning Date
08-20-2026
09-09-2025
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$0.18
52 Week High
$13.97
$6.80

Technical Indicators

Market Signals
Indicator
YJ
CURX
Relative Strength Index (RSI) 40.13 65.28
Support Level $1.38 $3.91
Resistance Level $1.87 $6.00
Average True Range (ATR) 0.13 0.39
MACD -0.03 -0.07
Stochastic Oscillator 21.43 73.77

Price Performance

Historical Comparison
YJ
CURX

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China using a membership-based model that leverages the power of social interaction. The group offers high-quality products at attractive prices and incentivizes members to promote its platform and share products with their social contacts. It empowers prime emerging brands and manufacturers with a deep understanding of market trends and customer behavior to produce high-quality products to meet the demands of members. The company also developed several private labels in the mass consumption field, which are sold on its own platform as well as offered and sold through external channels. It operates in the PRC, and substantially all the Group's revenue is derived from within the PRC.

About CURX Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.

Share on Social Networks: